AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
PC, Pancreatic Cancer: Click to Expand ⟱
Pancreatic Cancer: Hypoxia (low oxygen tension) is commonly found in solid tumors. Hypoxia-inducible factor-1 (HIF-1),is a key mediator of the cellular response to hypoxia and is overexpressed in a wide variety of solid tumors, including pancreatic cancer.
Nanog is highly expressed in CSCs compared to normal cells [93–97]
HIF-1↑
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
AntiCan↑, selectivity↑, Apoptosis↑, TumCCA↑, Bacteria↓, tumCV↓, selectivity↑, Apoptosis↑, TumCCA↑,
| - |
vitro+vivo, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
TumCP↓, HSP90↓, Akt↓, CDK4↓, TumCG↓, Apoptosis↑, AntiCan↑,
| - |
vitro+vivo, |
PC, |
MIA PaCa-2 |
|
|
|
ETC?, ROS↑, NADPH↓, AntiCan↑,
AntiCan↑, Dose↝, CellMemb↑, ChemoSen↑, MMP↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
ETC?, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
NADPH↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 3,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
HSP90↓, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
TumCG↓, 1,
Migration ⓘ
TumCP↓, 1,
Barriers & Transport ⓘ
CellMemb↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose↝, 1, selectivity↑, 2,
Functional Outcomes ⓘ
AntiCan↑, 4,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 18
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:21 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page